Cargando…

Mechanisms of Chinese Herbal Medicines for Diabetic Nephropathy Fibrosis Treatment

Diabetic nephropathy (DN) is a severe microvascular complication of diabetes mellitus that is one of the main causes of end-stage renal disease, causing considerable health problems as well as significant financial burden worldwide. The pathological features of DN include loss of normal nephrons, ma...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Tong, Bao, Yuhang, Su, Hong, Zheng, Rendong, Cao, Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9549772/
http://dx.doi.org/10.4103/2773-0387.353727
_version_ 1784805744742236160
author Jiang, Tong
Bao, Yuhang
Su, Hong
Zheng, Rendong
Cao, Lin
author_facet Jiang, Tong
Bao, Yuhang
Su, Hong
Zheng, Rendong
Cao, Lin
author_sort Jiang, Tong
collection PubMed
description Diabetic nephropathy (DN) is a severe microvascular complication of diabetes mellitus that is one of the main causes of end-stage renal disease, causing considerable health problems as well as significant financial burden worldwide. The pathological features of DN include loss of normal nephrons, massive fibroblast and myofibroblast hyperplasia, accumulation of extracellular matrix proteins, thickening of the basement membrane, and tubulointerstitial fibrosis. Renal fibrosis is a final and critical pathological change in DN. Although progress has been made in understanding the pathogenesis of DN fibrosis, current conventional treatment strategies may not be completely effective in preventing the disease’s progression. Traditionally, Chinese herbal medicines (CHMs) composed of natural ingredients have been used for symptomatic relief of DN. Increasing numbers of studies have confirmed that CHMs can exert a renoprotective effect in DN, and antifibrosis has been identified as a key mechanism. In this review, we summarize the antifibrotic efficacy of CHM preparations, single herbal medicines, and their bioactive compounds based on their effects on diminishing the inflammatory response and oxidative stress, regulating transforming growth factor, preventing epithelial-mesenchymal transition, and modulating microRNAs. We intend to provide patients of DN with therapeutic interventions that are complementary to existing options.
format Online
Article
Text
id pubmed-9549772
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-95497722022-10-11 Mechanisms of Chinese Herbal Medicines for Diabetic Nephropathy Fibrosis Treatment Jiang, Tong Bao, Yuhang Su, Hong Zheng, Rendong Cao, Lin Integrative Medicine in Nephrology and Andrology Review Article Diabetic nephropathy (DN) is a severe microvascular complication of diabetes mellitus that is one of the main causes of end-stage renal disease, causing considerable health problems as well as significant financial burden worldwide. The pathological features of DN include loss of normal nephrons, massive fibroblast and myofibroblast hyperplasia, accumulation of extracellular matrix proteins, thickening of the basement membrane, and tubulointerstitial fibrosis. Renal fibrosis is a final and critical pathological change in DN. Although progress has been made in understanding the pathogenesis of DN fibrosis, current conventional treatment strategies may not be completely effective in preventing the disease’s progression. Traditionally, Chinese herbal medicines (CHMs) composed of natural ingredients have been used for symptomatic relief of DN. Increasing numbers of studies have confirmed that CHMs can exert a renoprotective effect in DN, and antifibrosis has been identified as a key mechanism. In this review, we summarize the antifibrotic efficacy of CHM preparations, single herbal medicines, and their bioactive compounds based on their effects on diminishing the inflammatory response and oxidative stress, regulating transforming growth factor, preventing epithelial-mesenchymal transition, and modulating microRNAs. We intend to provide patients of DN with therapeutic interventions that are complementary to existing options. Medknow Publications & Media Pvt Ltd 2022 2022-09-27 /pmc/articles/PMC9549772/ http://dx.doi.org/10.4103/2773-0387.353727 Text en Copyright: © 2022 Integrative Medicine in Nephrology and Andrology https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.
spellingShingle Review Article
Jiang, Tong
Bao, Yuhang
Su, Hong
Zheng, Rendong
Cao, Lin
Mechanisms of Chinese Herbal Medicines for Diabetic Nephropathy Fibrosis Treatment
title Mechanisms of Chinese Herbal Medicines for Diabetic Nephropathy Fibrosis Treatment
title_full Mechanisms of Chinese Herbal Medicines for Diabetic Nephropathy Fibrosis Treatment
title_fullStr Mechanisms of Chinese Herbal Medicines for Diabetic Nephropathy Fibrosis Treatment
title_full_unstemmed Mechanisms of Chinese Herbal Medicines for Diabetic Nephropathy Fibrosis Treatment
title_short Mechanisms of Chinese Herbal Medicines for Diabetic Nephropathy Fibrosis Treatment
title_sort mechanisms of chinese herbal medicines for diabetic nephropathy fibrosis treatment
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9549772/
http://dx.doi.org/10.4103/2773-0387.353727
work_keys_str_mv AT jiangtong mechanismsofchineseherbalmedicinesfordiabeticnephropathyfibrosistreatment
AT baoyuhang mechanismsofchineseherbalmedicinesfordiabeticnephropathyfibrosistreatment
AT suhong mechanismsofchineseherbalmedicinesfordiabeticnephropathyfibrosistreatment
AT zhengrendong mechanismsofchineseherbalmedicinesfordiabeticnephropathyfibrosistreatment
AT caolin mechanismsofchineseherbalmedicinesfordiabeticnephropathyfibrosistreatment